 Home > Active Ingredient News > Immunology News > JAHA: Patients with rheumatoid arthritis who do not respond well to disease-altering antirheumatic drugs are at increased risk of acute coronary syndrome

JAHA: Patients with rheumatoid arthritis who do not respond well to disease-altering antirheumatic drugs are at increased risk of acute coronary syndrome

 Last Update: 2021-04-23
 Source: Internet
 Author: User

Tags

heroine drugs meaning

serotonin antagonist drugs

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

medsci.

Recently, a research article was published in JAHA, an authoritative journal in the field of cardiovascular diseases.

Cardiovascular events

The researchers used the Chang Gung research database to design a cohort study and identified 7,114 patients diagnosed with rheumatoid arthritis.

Diagnosing coronary syndrome stroke

The average follow-up time of subjects was 4.

It can be seen that patients with rheumatoid arthritis with poor response to DMARD have a higher risk of developing acute coronary syndromes than those of controls whose disease can be controlled by DMARD .

Patients with rheumatoid arthritis who have a poor response to DMARD have a higher risk of developing acute coronary syndromes than those with rheumatoid arthritis who can control the disease by DMARD

Original source:

Chung‐Yuan Hsu.

Patients With Rheumatoid Arthritis With an Inadequate Response to Disease-Modifying Antirheumatic Drugs at a Higher Risk of Acute Coronary Syndrome in this message

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High Purity 99% BPN14770 Zatolmilast 1606974-33-7 In Stock Fast Ship to USA

CAS No.: 1606974-33-7

Pharm Grade

$1-1.1/UNIT FOB

High quality Thymosin α1 Pure CAS 62304-98-7 Thymosin Alpha 1 Thymalfasin

CAS No.: 62304-98-7

Pharmacy Grade

$12-15/UNIT FOB

Top quantity Imiquimod CAS NO 99011-02-6 White crystalline powder 99% API

CAS No.: 99011-02-6

Pharmacy Grade

$1800-1850/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.